Morningside Venture Investments Limited 13D/13G Filings for NewAmsterdam Pharma Company N.V. (NAMS)

Morningside Venture Investments Limited 13D and 13G filings for NewAmsterdam Pharma Company N.V.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-09-19
9:30 pm
Purchase
2023-09-1113GNewAmsterdam Pharma Company N.V.
NAMS
Morningside Venture Investments Limited4,060,923
4.930%
4,060,923increase
(New Position)
Filing